UK markets open in 6 hours 3 minutes

Cartesian Therapeutics, Inc. (RNAC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
23.25+0.05 (+0.19%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4454
Avg. Estimate-0.88-0.9-3.21-2.95
Low estimate-1.5-1.5-6.3-4.86
High estimate-0.27-0.33-1.38-1.5
Year ago EPS-4.2-2.1-49.8-3.21
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4443
Avg. Estimate1.25M1.25M16.75M16.58M
Low estimateN/AN/AN/AN/A
High estimate5M5M47M49.75M
Year ago sales5.94M5.25M26M16.75M
Sales growth (year/est)-78.90%-76.20%-35.60%-1.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-2.61-2.4-1.75-1.05
Actual EPS-4.2-2.1-1.8-41.7
Difference-1.590.3-0.05-40.65
Surprise %-60.90%12.50%-2.90%-3,871.40%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.88-0.9-3.21-2.95
7 days ago-0.88-0.9-3.21-2.95
30 days ago-1.5-1.5-3.9-1.5
60 days ago-0.03-0.03-0.1-0.05
90 days ago-0.05-0.05-0.13-0.12
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1N/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesRNACIndustrySector(s)S&P 500
Current qtr.79.00%N/AN/AN/A
Next qtr.57.10%N/AN/AN/A
Current year93.60%N/AN/AN/A
Next year8.10%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A